+CpG辅助性SARS-CoV-2无活化疫苗在小鼠中的免疫性

Jie Yang1, Boran Li2, Dongsheng Yang1

  • 1Wuhan Institute of Biological Products Co. Ltd., No. 1 Huangjin Industrial Park Road, Jiangxia District, Wuhan 430200, China; National Engineering Technology Research Center of Combined Vaccines, No. 1 Huangjin Industrial Park Road, Jiangxia District, Wuhan 430200, China.

Vaccine
|August 28, 2023
PubMed
概括

这项研究表明,使用氧化 (Alum) 和CpG辅助剂的SARS-CoV-2的非活化疫苗候选物有效地提高了小鼠的免疫反应. 这种新型辅助剂组合有可能改善针对新兴变种的疫苗开发.

相关概念视频